SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Oramed Reports Patent Grant In Europe For Oral Delivery Of Proteins

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) and (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the European Patent

Benzinga · 01/28/2020 12:27